Aspen Pharmacare Holdings (JSE:APN) Total Operating Expense: R10,712 Mil (TTM As of Dec. 2025)


JSE:APN Aspen Pharmacare Holdings Ltd JSE:APN
74 GF Score
Price R151.05
GF Value R170.74
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings Total Operating Expense?

Aspen Pharmacare Holdings JSE:APN +2.70% 74 Total Operating Expense is R10,712 Mil as of Dec. 2025. GuruFocus rates JSE:APN with a GF Score™ of 74/100 and a GF Value™ of R170.74 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Aspen Pharmacare Holdings's Total Operating Expense for the six months ended in Dec. 2025 was R5,632 Mil. Aspen Pharmacare Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was R10,712 Mil.

Aspen Pharmacare Holdings Total Operating Expense Related Terms

Aspen Pharmacare Holdings Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings Total Operating Expense Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,664.00 9,515.00 10,161.00 9,008.00 10,504.00

Aspen Pharmacare Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,812.00 3,196.00 5,424.00 5,080.00 5,632.00
JSE:APN
74GF Score
Aspen Pharmacare Holdings Ltd JSE:APN
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was R10,712 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of R10,712 Mil mean?
Aspen Pharmacare Holdings (JSE:APN) has a Total Operating Expense of R10,712 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Aspen Pharmacare Holdings and its competitors.
Is Aspen Pharmacare Holdings' Total Operating Expense too high?
Aspen Pharmacare Holdings' current Total Operating Expense is R10,712 Mil. Overall, Aspen Pharmacare Holdings has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' Total Operating Expense compare to ZTS and UTHR?
Aspen Pharmacare Holdings' Total Operating Expense of R10,712 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Aspen Pharmacare Holdings and its competitors. Aspen Pharmacare Holdings's current Total Operating Expense is R10,712 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (JSE:APN) is currently considered Modestly Undervalued. The stock's GF Value™ is R170.74, compared to a current price of R151.05 — trading 11.5% below its estimated fair value. The current Total Operating Expense is R10,712 Mil. Aspen Pharmacare Holdings' overall GF Score™ is 74/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Aspen Pharmacare Holdings (JSE:APN), the current Total Operating Expense is R10,712 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Pharmacare Holdings (JSE:APN) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of R151.05 is trading 11.5% below its estimated GF Value™ of R170.74. GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.

Key valuation signals for JSE:APN:

  • Total Operating Expense: R10,712 Mil
  • GF Value™: R170.74 vs. price of R151.05 (11.5% below fair value)
  • GF Score™: 74/100 with 10 warning signs

No single metric tells the full story. See the JSE:APN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
74GF Score

Get the complete analysis for JSE:APN

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R151.05
Price
R170.74
GF Value